Clinical Trial

An Examination of Brown Adipose Tissue and Energy Expenditure in Infants

Study acronym: Born2Burn
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 31, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
Excess fetal adipose tissue growth during intrauterine development increases future obesity risk. Development of brown adipose tissue, a highly thermogenic organ in utero, may affect postnatal energy expenditure, thus influencing obesity risk. This pilot research study is designed to understand the developmental origins of energy balance by examining maternal and neonatal factors that influence neonatal brown adipose tissue and to quantify its physiological relevance to energy expenditure in human neonates.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-08-24; most recent amendment 2025-05-27.
Trial Details
NCT Number NCT05517967
Lead Sponsor Pennington Biomedical Research Center
Conditions Cold Induced Thermogenesis
Enrollment 60 participants
Start Date 2022-08-17
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-31